Anti-Human TGFB2 Recombinant Antibody

Product Information

Catalog Number	YR1117
Product Name	Anti-Human TGFB2 Recombinant Antibody
Molecular Name	Lerdelimumab
Alias	Anti-TGFB2 Recombinant Antibody, Research Grade Lerdelimumab
CAS Number	285985-06-0
Target	TGFB2[Homo sapiens]
Isotype	IgG4
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Lerdelimumab (CAT-152, intended trade name Trabio) is a human monoclonal antibody and an immunosuppressive drug targeting TGF beta 2. It was being developed to reduce scarring after glaucoma drainage surgery. Development was stopped in late 2005 after unsuccessful trial results for that condition.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price